Detalhe da pesquisa
1.
Development of a HiBiT-tagged reporter hepatitis E virus and its utility as an antiviral drug screening platform.
J Virol
; 97(9): e0050823, 2023 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37681960
2.
Development of Recombinant Infectious Hepatitis E Virus Harboring the nanoKAZ Gene and Its Application in Drug Screening.
J Virol
; 96(6): e0190621, 2022 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35107380
3.
Possible biological mechanisms of entecavir versus tenofovir disoproxil fumarate on reducing the risk of hepatocellular carcinoma.
J Gastroenterol Hepatol
; 38(5): 683-691, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918402
4.
Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon-lambda 3 induction in chronic hepatitis B patients.
Hepatol Res
; 52(7): 586-596, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35352445
5.
Immunomodulatory Mechanism of Acyclic Nucleoside Phosphates in Treatment of Hepatitis B Virus Infection.
Hepatology
; 71(5): 1533-1545, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31529730
6.
IFN-λ3 as a host immune response in acute hepatitis E virus infection.
Cytokine
; 125: 154816, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31465972
7.
Anti-viral effects of interferon-λ3 on hepatitis B virus infection in cell culture.
Hepatol Res
; 50(3): 283-291, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31756766
8.
Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population.
Hum Mol Genet
; 26(3): 650-659, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28062665
9.
Key HLA-DRB1-DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine.
Hepatology
; 68(3): 848-858, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29534301
10.
Association of serum interferon-λ3 levels with hepatocarcinogenesis in chronic hepatitis C patients treated with direct-acting antiviral agents.
Hepatol Res
; 49(5): 500-511, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30623518
11.
Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.
Gut
; 67(2): 362-371, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789659
12.
Pretreatment serum levels of interferon-gamma-inducible protein-10 are associated with virologic response to telaprevir-based therapy.
Cytokine
; 88: 29-36, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27541605
13.
Hepatitis B virus vaccination-related seroprevalence among health-care personnel in a Japanese tertiary medical center.
Hepatol Res
; 46(13): 1330-1337, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26931185
14.
Geographic distribution and characteristics of genotype A hepatitis B virus infection in acute and chronic hepatitis B patients in Japan.
J Gastroenterol Hepatol
; 31(1): 180-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26110395
15.
Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults.
Hepatology
; 59(1): 89-97, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23897861
16.
Regional disparities in interferon therapy for chronic hepatitis C in Japan: a nationwide retrospective cohort study.
BMC Public Health
; 15: 566, 2015 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26088426
17.
Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID).
J Biol Chem
; 288(44): 31715-27, 2013 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24025329
18.
Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus.
Hepatology
; 57(5): 1705-15, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23213063
19.
Pretreatment prediction of the outcome of response-guided peginterferon-α and ribavirin therapy for chronic hepatitis C.
J Gastroenterol Hepatol
; 29(12): 1996-2005, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24910341
20.
Nucleos(t)ide analogs for hepatitis B virus infection differentially regulate the growth factor signaling in hepatocytes.
Hepatol Commun
; 8(1)2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180972